Coastwise Capital Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Sell
2,707
-739
-21% -$97.4K 0.2% 102
2026
Q1
$480K Sell
3,446
-306
-8% -$42.9K 0.27% 74
2025
Q4
$460K Sell
3,752
-2,755
-42% -$335K 0.23% 90
2025
Q3
$722K Buy
6,507
+41
+0.6% +$4.66K 0.51% 53
2025
Q2
$717K Buy
6,466
+8
+0.1% +$851 0.57% 48
2025
Q1
$724K Sell
6,458
-1,360
-17% -$140K 0.61% 43
2024
Q4
$722K Sell
7,818
-775
-9% -$69.8K 0.58% 45
2024
Q3
$720K Buy
8,593
+813
+10% +$62K 0.59% 43
2024
Q2
$534K Sell
7,780
-161
-2% -$10.7K 0.51% 55
2024
Q1
$582K Buy
7,941
+193
+2% +$14.8K 0.54% 53
2023
Q4
$628K Buy
7,748
+19
+0.2% +$1.48K 0.64% 44
2023
Q3
$579K Buy
7,729
+2,439
+46% +$188K 0.66% 46
2023
Q2
$408K Sell
5,290
-1,060
-17% -$84.5K 0.46% 60
2023
Q1
$527K Sell
6,350
-338
-5% -$28K 0.6% 48
2022
Q4
$574K Sell
6,688
-3,463
-34% -$274K 0.68% 38
2022
Q3
$626K Sell
10,151
-259
-2% -$16.3K 0.99% 34
2022
Q2
$643K Sell
10,410
-138
-1% -$8.54K 0.78% 35
2022
Q1
$627K Buy
+10,548
New +$674K 0.78% 37

Other funds holding GILD

Coastwise Capital Group's GILD Position: Q2 2026 in Review

Coastwise Capital Group reduced its Gilead Sciences (GILD) stake by 21% in Q2 2026, selling an estimated $97.4K and leaving 2,707 shares worth $342K. The position accounts for 0.2% of the portfolio, ranked #102.

Coastwise Capital Group first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. The position peaked at $724K in Q1 2025. 486 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Coastwise Capital Group held 2,707 shares of Gilead Sciences worth $342K as of Q2 2026.
  • Coastwise Capital Group sold 739 Gilead Sciences shares in Q2 2026, an estimated $97.4K.
  • Gilead Sciences made up 0.2% of Coastwise Capital Group's portfolio in Q2 2026, its #102 holding.
  • Coastwise Capital Group first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
  • Coastwise Capital Group's Gilead Sciences position peaked at $724K in Q1 2025.
  • 486 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Coastwise Capital Group's 13F filing for Q2 2026, filed 16 Jul 2026.